Cited by 134Coagulation, Bradykinin, Polyphosphates, and AngioedemaRenin-Angiotensin System StudiesPineapple and bromelain studies

The DOI matches its Crossref record; 198 of the 205 references it cites were found in a registry or an index.

The role of kinin receptors in cancer and therapeutic opportunities

Open access

da Costa, Patrícia L.N., Sirois, Pierre, Tannock, Ian F., Chammas, Roger·2014·Cancer Letters

DOI 10.1016/j.canlet.2013.12.009

Open this paper in CoChat — free account

Abstract

Kinins are generated within inflammatory tissue microenvironments, where they exert diverse functions, including cell proliferation, leukocyte activation, cell migration, endothelial cell activation and nociception. These pleiotropic functions depend on signaling through two cross talking receptors, the constitutively expressed kinin receptor 2 (B2R) and the inducible kinin receptor 1 (B1R). We have reviewed evidence, which supports the concept that kinin receptors, especially kinin receptor 1, are promising targets for cancer therapy, since (1) many tumor cells express aberrantly high levels of these receptors; (2) some cancers produce kinins and use them as autocrine factors to stimulate their growth; (3) activation of kinin receptors leads to activation of macrophages, dendritic cells and other cells from the tumor microenvironment; (4) kinins have pro-angiogenic properties; (5) kinin receptors have been implicated in cancer migration, invasion and metastasis; and (6) selective antagonists for either B1R or B2R have shown anti-proliferative, anti-inflammatory, anti-angiogenic and anti-migratory properties. The multiple cross talks between kinin receptors and renin-angiotensin system (RAS) as well as its implications for targeting KKS or RAS for the treatment of malignancies are also discussed. It is expected that B1R antagonists would interfere less with housekeeping functions and therefore would be attractive compounds to treat selected types of cancer. Reliable clinical studies are needed to establish the translatability of these data to human settings and the usefulness of kinin receptor antagonists.

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2013.12.009

Cites

198 of 198 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,786
Pharmacology of bradykinin and related kinins.
Regoli, D. C., & Barabé, J. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06836-x · Cited by 1,900
Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
Papapetropoulos, A., García‐Cardeña, G., Madri, J. A., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119868 · Cited by 1,195
THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME
Skeggs, L. T., Kahn, J. R., & Shumway, N. P. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.3.295 · Cited by 1,035
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Leeb-Lundberg, L. M. F., Marceau, F., Müller‐Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 956
BRADYKININ, A HYPOTENSIVE AND SMOOTH MUSCLE STIMULATING FACTOR RELEASED FROM PLASMA GLOBULIN BY SNAKE VENOMS AND BY TRYPSIN
Silva, M. R. E., Beraldo, W. T., & Rosenfeld, G. (1949) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1949.156.2.261 · Cited by 828
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Villanueva, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26022 · Cited by 738
The renin-angiotensin-aldosterone system
Vecsei, P., Hackenthal, E., & Ganten, D. (1978) · Journal of Molecular Medicine · doi:10.1007/bf01477448 · Cited by 604
Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
Welch, H. G., & Albertsen, P. C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp278 · Cited by 578
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
Tsutsumi, Y., Matsubara, H., Masaki, H., Kurihara, H., Murasawa, S., Takai, S., Miyazaki, M., Nozawa, Y., Ozono, R., Nakagawa, K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7886 · Cited by 560
Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin
Murohara, T., Horowitz, J. R., Silver, M., Tsurumi, Y., Chen, D., Sullivan, A. B., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.1.99 · Cited by 518
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
AbdAlla, S., Lother, H., & Quitterer, U. (2000) · Nature · doi:10.1038/35024095 · Cited by 503
The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors
Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., & Tannock, I. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1664 · Cited by 499
Self-citation
Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness
AbdAlla, S., Lother, H., el Massiery, A., & Quitterer, U. (2001) · Nature Medicine · doi:10.1038/nm0901-1003 · Cited by 496
Kinin receptors in pain and inflammation
Couture, R., Harrisson, M., Vianna, R. M. J., & Cloutier, F. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01318-8 · Cited by 472
Competitive antagonists of bradykinin
Vavrek, R. J., & Stewart, J. M. (1985) · Peptides · doi:10.1016/0196-9781(85)90033-6 · Cited by 464
Expression cloning of a human B1 bradykinin receptor.
Menke, J. G., Borkowski, J. A., Bierilo, K. K., MacNeil, T., Derrick, A., Schneck, K., Ransom, R. W., Strader, C. D., Linemeyer, D. L., & Hess, J. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31844-6 · Cited by 459
The Kallikrein-Kinin System: Current and Future Pharmacological Targets
Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J., Marceau, F., & Adam, A. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.srj05001x · Cited by 457
THE EXISTENCE OF TWO FORMS OF HYPERTENSIN
Skeggs, L. T., Marsh, W. H., Kahn, J. R., & Shumway, N. P. (1954) · The Journal of Experimental Medicine · doi:10.1084/jem.99.3.275 · Cited by 457
Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors
Pesquero, J. B., Araújo, R. C., Heppenstall, P. A., Stucky, C. L., Silva, J. A., Walther, T., de Oliveira, S. M., Pesquero, J. L., Paiva, A. C. M., Calixto, J. Β., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120035997 · Cited by 376
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
The renin-angiotensin system and malignancy
Ager, E. I., Neo, J. H., & Christophi, C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn171 · Cited by 296
Kinins in pain and inflammation
Calixto, J. Β., Cabrini, D. A., Ferreira, J., & Campos, M. M. (2000) · Pain · doi:10.1016/s0304-3959(00)00335-3 · Cited by 293
Receptors for bradykinin in rabbit aortae
Regoli, D. C., Barabé, J., & Park, W. K. (1977) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y77-115 · Cited by 260
Kinin B 1 receptors: key G‐protein‐coupled receptors and their role in inflammatory and painful processes
Calixto, J. Β., Medeiros, R., Fernandes, E. S., Ferreira, J., Cabrini, D. A., & Campos, M. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706012 · Cited by 258
Bradykinin stimulates tumor necrosis factor and interleukin‐1 release from macrophages
Tiffany, C. W., & Burch, R. M. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81331-6 · Cited by 242
Bradykinin Promotes the Chemotactic Invasion of Primary Brain Tumors
Montana, V., & Sontheimer, H. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3825-10.2011 · Cited by 214
New, long‐acting, potent bradykinin antagonists
Lembeck, F., Griesbacher, T., Eckhardt, M., Henke, S., Breipohl, G., & Knolle, J. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12169.x · Cited by 213
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma
Prados, M. D., Schold, S. C., Fine, H. A., Jaeckle, K. A., Hochberg, F. H., Mechtler, L. L., Fetell, M. R., Phuphanich, S., Feun, L. G., Janus, T. J., et al. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.96 · Cited by 207
The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.
Yoshiji, H., Kuriyama, S., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., Tsujinoue, H., & Fukui, H. (2001) · PubMed · Cited by 207
Autocrine and paracrine signaling through neuropeptide receptors in human cancer
Heasley, L. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204183 · Cited by 200
Treatment of Severe Systemic Inflammatory Response Syndrome and Sepsis With a Novel Bradykinin Antagonist, Deltibant (CP-0127) Results of a Randomized, Double-blind, Placebo-Controlled Trial
Fein, A. M. (1997) · JAMA · doi:10.1001/jama.277.6.482 · Cited by 199
The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.
Schanstra, J. P., Bataillé, E., Castano, M. E. M., Barascud, Y., Hirtz, C., Pesquero, J. B., Pécher, C., Gauthier, F., Girolami, J., & Bascands, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1359 · Cited by 196
Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression
Stefanidakis, M., & Koivunen, E. (2006) · Blood · doi:10.1182/blood-2006-02-005363 · Cited by 178
Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells
Bogle, R., Coade, S. B., Moncada, S., Pearson, J. D., & Mann, G. E. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81154-4 · Cited by 167
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
Matsumura, Y., Kimura, M., Yamamoto, T., & Maeda, H. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01563.x · Cited by 163
Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors
Kuhr, F., Lowry, J., Zhang, Y., Brovkovych, V. M., & Skidgel, R. A. (2010) · Neuropeptides · doi:10.1016/j.npep.2009.12.004 · Cited by 154
Studies on the induction of pharmacological responses to des‐Arg9‐bradykinin in vitro and in vivo
Bouthillier, J., deBlois, D., & Marceau, F. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11319.x · Cited by 153
The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine‐induced mechanical hyperalgesia in the rat
Aj, D., & Perkins, M. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb16174.x · Cited by 151
Cross-talk between G Protein–Coupled Receptor and Epidermal Growth Factor Receptor Signaling Pathways Contributes to Growth and Invasion of Head and Neck Squamous Cell Carcinoma
Thomas, S. M., Bhola, N. E., Zhang, Q. H., Contrucci, S., Wentzel, A. L., Freilino, M. L., Gooding, W. E., Siegfried, J. M., Chan, D. C. F., & Grandis, J. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2876 · Cited by 151
Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts.
Pan, Z. K., Zuraw, B. L., Lung, C.-C., Prossnitz, E. R., Browning, D. D., & Ye, R. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119009 · Cited by 149
The bradykinin/B1 receptor promotes angiogenesis by up‐regulation of endogenous FGF‐2 in endothelium via the nitric oxide synthase pathway
Parenti, A., Morbidelli, L., Ledda, F., Granger, H. J., & Ziche, M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0503fje · Cited by 148
Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system
Schulze-Topphoff, U., Prat, A., Prozorovski, T., Siffrin, V., Paterka, M., Herz, J., Bendix, I., Ifergan, I., Schadock, I., Mori, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1980 · Cited by 131
Angiotensin I–Converting Enzyme Inhibitors Are Allosteric Enhancers of Kinin B1 and B2 Receptor Function
Erdös, E. G., Tan, F., & Skidgel, R. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.144600 · Cited by 130
Kinin receptors
Marceau, F., & Bachvarov, D. R. (1998) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02737658 · Cited by 129
Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer.
Maeda, H., Matsumura, Y., & Kato, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37555-0 · Cited by 128
Autoregulation of Bradykinin Receptors: Agonists in the Presence of Interleukin-1β Shift the Repertoire of Receptor Subtypes from B2 to B1 in Human Lung Fibroblasts
Phagoo, S. B., Poole, S., & Leeb-Lundberg, L. M. F. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.325 · Cited by 128
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition
Hanif, K., Bid, H. K., & Konwar, R. (2009) · Hypertension Research · doi:10.1038/hr.2009.184 · Cited by 126
Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases
Neo, J. H., Malcontenti‐Wilson, C., Muralidharan, V., & Christophi, C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04797.x · Cited by 125
SSR240612 [(2 R)-2-[((3 R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2 R,6 S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization
Gougat, J., Ferrari, B., Sarran, L., Planchenault, C., Poncelet, M., Maruani, J., Alonso, R., Cudennec, A., Croci, T., Guagnini, F., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059527 · Cited by 124
Mechanisms of Disease: the tissue kallikrein–kinin system in hypertension and vascular remodeling
Madeddu, P. R., Emanueli, C., & El-Dahr, S. S. (2007) · Nature Reviews Nephrology · doi:10.1038/ncpneph0444 · Cited by 124
Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin.
Parries, G. S., Hoebel, R., & Racker, E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2648 · Cited by 122
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group
Warren, K. E., Jakacki, R. I., Widemann, B. C., Aikin, A. A., Libucha, M., Packer, R. J., Vézina, G., Reaman, G. H., Shaw, D., Krailo, M., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0172-7 · Cited by 119
Effect of glucocorticoids, monokines and growth factors on the spontaneously developing responses of the rabbit isolated aorta to des‐Arg9‐bradykinin
deBlois, D., Bouthillier, J., & Marceau, F. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11487.x · Cited by 117
Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system
Wotherspoon, G., & Winter, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01561-5 · Cited by 117
Induction of Functional Bradykinin B 1 -Receptors in Normotensive Rats and Mice Under Chronic Angiotensin-Converting Enzyme Inhibitor Treatment
Marin‐Castaño, M. E., Schanstra, J. P., Neau, E., Praddaude, F., Pécher, C., Ader, J., Girolami, J., & Bascands, J. (2002) · Circulation · doi:10.1161/hc0502.102965 · Cited by 114
Kinins and kinin receptors: importance for the activation of leukocytes
Böckmann, S., & Paegelow, I. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.5.587 · Cited by 111
Bradykinin receptor subtype 1 expression and function in prostate cancer.
Taub, J. S., Guo, R., Leeb-Lundberg, L. M. F., Madden, J. F., & Daaka, Y. (2003) · PubMed · Cited by 108
Effects of the Bradykinin Antagonist Bradycor™ (Deltibant, CP-1027) in Severe Traumatic Brain Injury: Results of a Multi-Center, Randomized, Placebo-Controlled Trial
Marmarou, A., NICHOLS, J. S., BURGESS, J., Newell, D., Troha, J. M., Burnham, D. B., & Pitts, L. (1999) · Journal of Neurotrauma · doi:10.1089/neu.1999.16.431 · Cited by 107
Kinin B1 Receptor Up-Regulation after Lipopolysaccharide Administration: Role of Proinflammatory Cytokines and Neutrophil Influx
Passos, G. F., Fernandes, E. S., Campos, M. M., Araújo, J. G. V. C., Pesquero, J. L., de Souza, G. E. P., Avellar, M. C. W., Teixeira, M. M., & Calixto, J. Β. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1839 · Cited by 105
Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study
Matsumura, Y., Maruo, K., Kimura, M., Yamamoto, T., Konno, T., & Maeda, H. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01910.x · Cited by 104
Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues
Wu, J., Akaike, T., Hayashida, K., Miyamoto, Y., Nakagawa, T., Miyakawa, K., Müller‐Esterl, W., & Maeda, H. (2001) · International Journal of Cancer · doi:10.1002/ijc.10142 · Cited by 101
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance
Avgeris, M., Mavridis, K., & Scorilas, A. (2012) · Biological Chemistry · doi:10.1515/hsz-2011-0260 · Cited by 95
PGE2release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase-2 induction
Pang, L., & Knox, A. J. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.273.6.l1132 · Cited by 94
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF‐2 effects
Morbidelli, L., Parenti, A., Giovannelli, L., Granger, H. J., Ledda, F., & Ziche, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701943 · Cited by 93
Participation of kallikrein–kinin system in different pathologies
Costa-Neto, C. M., Dillenburg-Pilla, P., Heinrich, T. A., Parreiras‐e‐Silva, L. T., Pereira, M. G. A. G., Reis, R. I., & de Souza, P. C. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.08.003 · Cited by 92
Bradykinin-Induced Chemotaxis of Human Gliomas Requires the Activation of KCa3.1 and ClC-3
Cuddapah, V. A., Turner, K. L., Seifert, S., & Sontheimer, H. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3980-12.2013 · Cited by 90
RNAs induced by Epstein–Barr virus nuclear antigen 2 in lymphoblastoid cell lines
Zhao, B., Maruo, S., Cooper, A., Chase, M. R., Johannsen, E., Kieff, E. D., & Cahir-McFarland, E. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510612103 · Cited by 88
Host Stromal Bradykinin B2 Receptor Signaling Facilitates Tumor-Associated Angiogenesis and Tumor Growth
Ikeda, Y., Hayashi, I., Kamoshita, E., Yamazaki, A., Endo, H., Ishihara, K., Yamashina, S., Tsutsumi, Y., Matsubara, H., & Majima, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3589 · Cited by 88
Kallikrein–kinin in infection and cancer
Maeda, H., Wu, J., Okamoto, T., Maruo, K., & Akaike, T. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00104-6 · Cited by 83
Activation of kinin B1 receptors induces chemotaxis of human neutrophils
Ehrenfeld, P., Millán, C., Matus, C. E., Figueroa, J. E., Burgos, R. A., Nualart, F., Bhoola, K. D., & Figueroa, C. D. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205744 · Cited by 82
Altered Neutrophil Homeostasis in Kinin B1 Receptor-Deficient Mice
Araújo, R. C., Kettritz, R., Fichtner, I., Paiva, A. C. M., Pesquero, J. B., & Bäder, M. (2001) · Biological Chemistry · doi:10.1515/bc.2001.014 · Cited by 78
Bradykinin antagonists: discovery and development
Stewart, J. M. (2003) · Peptides · doi:10.1016/j.peptides.2003.10.016 · Cited by 77
Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells
Barki‐Harrington, L., Bookout, A. L., Wang, G., Lamb, M. E., Leeb-Lundberg, L. M. F., & Daaka, Y. (2003) · Biochemical Journal · doi:10.1042/bj20021708 · Cited by 74
Different cross-talk sites between the renin–angiotensin and the kallikrein–kinin systems
Su, J. B. (2013) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312474854 · Cited by 74
p21ras-induced responsiveness of phosphatidylinositol turnover to bradykinin is a receptor number effect.
Downward, J., de Gunzburg, J., Riehl, R., & Weinberg, R. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5774 · Cited by 73
Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts
Esseghir, S., Reis‐Filho, J., Kennedy, A., James, M., O'Hare, M. J., Jeffery, R. E., Poulsom, R., & Isacke, C. M. (2006) · The Journal of Pathology · doi:10.1002/path.2071 · Cited by 73
Roles of bradykinin in vascular permeability and angiogenesis in solid tumor
Ishihara, K., Kamata, M., Hayashi, I., Yamashina, S., & Majima, M. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00193-x · Cited by 72
Bradykinin‐induced cell migration and COX‐2 production mediated by the bradykinin B1 receptor in glioma cells
Lu, D., Leung, Y., Huang, S.-M., & Wong, K. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22520 · Cited by 71
Molecular cloning and expression of rat bradykinin B1 receptor
Ni, A., Chai, K. X., Chao, L., & Chao, J. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00163-8 · Cited by 71
NADPH oxidase 2-derived reactive oxygen species signal contributes to bradykinin-induced matrix metalloproteinase-9 expression and cell migration in brain astrocytes
Lin, C., Hsieh, H., Shih, R., Chi, P., Cheng, S., Chen, J., & Yang, C. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-35 · Cited by 71
Molecular Responses of Endothelial Tissue to Kinins
Busse, R., & Fleming, I. (1996) · Diabetes · doi:10.2337/diab.45.1.s8 · Cited by 70
Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis is increased by expression of a mutant ras oncogene
Roberts, R. A., & Gullick, W. J. (1989) · Journal of Cell Science · doi:10.1242/jcs.94.3.527 · Cited by 68
Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study
Winden, A. W. J. O., Gast, M. W., Beijnen, J. H., Rutgers, E. J. T., Grobbee, D. E., Peeters, P. H. M., & van Gils, C. H. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-4 · Cited by 67
Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-α. Effects dependent on activation of NF-κB and MAP kinases
Brechter, A. B., Persson, E., Lundgren, I., & Lerner, U. H. (2008) · Bone · doi:10.1016/j.bone.2008.02.003 · Cited by 67
Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway
Molina, L., Matus, C. E., Astroza, Á., Pavicic, F., Tapia, E., Toledo, C., Perez, J. A., Nualart, F., González, C. B., Burgos, R. A., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0314-4 · Cited by 66
Bradykinin receptors: Characterization, distribution and mechanisms of signal transduction
Roberts, R. A. (1989) · Progress in Growth Factor Research · doi:10.1016/0955-2235(89)90013-6 · Cited by 66
Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family
Ehrenfeld, P., Matus, C. E., Pavicic, F., Toledo, C., Nualart, F., González, C. B., Burgos, R. A., Bhoola, K. D., & Figueroa, C. D. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0109012 · Cited by 66
Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
Bathon, J. M., Manning, D. C., GOLDMAN, D. W., Towns, M. C., & Proud, D. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11244-5 · Cited by 66
The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors
Patel, K. J., & Tannock, I. F. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-356 · Cited by 65
Self-citation
Expression of tissue and plasma kallikreins and kinin B1and B2receptors in lung cancer
Chee, J., Naran, A., Misso, N. L. A., Thompson, P. J., & Bhoola, K. D. (2008) · Biological Chemistry · doi:10.1515/bc.2008.139 · Cited by 63
BRADYKININ INDUCED MITOGENESIS OF ANDROGEN INDEPENDENT PROSTATE CANCER CELLS
Barki‐Harrington, L., & Daaka, Y. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66305-7 · Cited by 60
Tissue Kallikrein Is Essential for Invasive Capacity of Circulating Proangiogenic Cells
Spinetti, G., Fortunato, O., Cordella, D., Portararo, P., Kränkel, N., Katare, R., Sala‐Newby, G. B., Richer, C., Vincent, M., Alhenc‐Gelas, F., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.236786 · Cited by 60
Lack of Evidence for AT1R/B2R Heterodimerization in COS-7, HEK293, and NIH3T3 Cells
Hansen, J. L., Hansen, J. T., Speerschneider, T., Lyngsø, C., Erikstrup, N., Burstein, E. S., Weiner, D. M., Walther, T., Makita, N., Iiri, T., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804607200 · Cited by 59
Protein kinase C (PKC)-δ/-ε mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin
Greco, S., Storelli, C., & Marsigliante, S. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06433 · Cited by 59
Nitric oxide pathway‐mediated relaxant effect of bradykinin in the guinea‐pig isolated trachea
Schlemper, V., & Calixto, J. Β. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14027.x · Cited by 58
Analgesic Efficacy of Bradykinin B1 Antagonists in a Murine Bone Cancer Pain Model
Sevcik, M. A., Ghilardi, J. R., Halvorson, K. G., Lindsay, T. H., Kubota, K., & Mantyh, P. W. (2005) · Journal of Pain · doi:10.1016/j.jpain.2005.06.010 · Cited by 58
Kinin receptors are expressed in human astrocytic tumour cells
Raidoo, D. M., Sawant, S., Mahabeer, R., & Bhoola, K. D. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00097-1 · Cited by 57
Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a “biased agonist” mechanism
Chan, D. C. F., Gera, L., Stewart, J. M., Helfrich, B. A., Verella-Garcia, M., Johnson, G. L., Barón, A. E., Yang, J., Puck, T. T., & Bunn, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072077299 · Cited by 56
Bradykinin-related compounds as new drugs for cancer and inflammation
Stewart, J. M., Gera, L., Chan, D. C. F., Bunn, P. A., York, E. J., Simkeviciene, V., & Helfrich, B. A. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-030 · Cited by 55
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
Shakur‐Still, H., Andrews, P., Asser, T., Balica, L., Boeriu, C. M., Quintero, J. D. C., Dewan, Y., Druwé, P., Fletcher, O., Frost, C. D., et al. (2009) · Trials · doi:10.1186/1745-6215-10-109 · Cited by 55
Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration
Hooper, C. M., Baltic, S., Misso, N. L. A., Bhoola, K. D., Foster, P. S., Thompson, P. J., & Fogel‐Petrovic, M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0106055 · Cited by 55
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer
Alexopoulou, D. K., Papadopoulos, I. N., & Scorilas, A. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.03.002 · Cited by 53
Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture
Greco, S., Elia, M. G., Muscella, A., Romano, S., Storelli, C., & Marsigliante, S. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06052 · Cited by 53
Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells
Ehrenfeld, P., Conejeros, I., Pavicic, F., Matus, C. E., González, C. B., Quest, A. F. G., Bhoola, K. D., Poblete, M. T., Burgos, R. A., & Figueroa, C. D. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.09.020 · Cited by 50
Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: Mechanistic and clinical aspects
Kontos, C. K., Mavridis, K., Talieri, M., & Scorilas, A. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-11-0791 · Cited by 49
Targeting the ‘Janus face' of the B2-bradykinin receptor
Blaes, N., & Girolami, J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.827664 · Cited by 49
Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS
Dabiré, H., Barthélémy, I., Blanchard‐Gutton, N., Sambin, L., Sampedrano, C. C., Gouni, V., Unterfinger, Y., Aguilar, P., Thibaud, J. L., Ghaleh, B., et al. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0240-6 · Cited by 48
A Potential Role of Bradykinin in Angiogenesis and Growth of S-180 Mouse Tumors
Ishihara, K., Hayashi, I., Yamashina, S., & Majima, M. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.87.318 · Cited by 48
Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma
Dlamini, Z., & Bhoola, K. D. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.021444 · Cited by 48
Human ACE and bradykinin B 2 receptors form a complex at the plasma membrane
Chen, Z., Deddish, P. A., Minshall, R. D., Becker, R. P., Erdös, E. G., & Tan, F. (2006) · The FASEB Journal · doi:10.1096/fj.06-6113com · Cited by 48
Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells
Greco, S., Muscella, A., Elia, M. G., Romano, S., Storelli, C., & Marsigliante, S. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20052 · Cited by 47
Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth
Correa, M., Machado, J., Carneiro, C. R. W., Pesquero, J. B., Bäder, M., Travassos, L. R., Chammas, R. J., & Jasiulionis, M. G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20673 · Cited by 47
Self-citation
Migratory Responses of Polymorphonuclear Leukocytes to Kinin Peptides
Paegelow, I., Trzeczak, S., Böckmann, S., & Vietinghoff, G. (2002) · Pharmacology · doi:10.1159/000063797 · Cited by 45
Mechanism of Bradykinin-Induced Ca2+ Mobilization in MG63 Human Osteosarcoma Cells
Wang, J.-W., Su, W., Law, Y., Lu, C., Chen, Y., Wang, J., Chang, H.-J., Chen, W., & Jan, C. (2001) · Hormone Research in Paediatrics · doi:10.1159/000050011 · Cited by 45
Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c‐Src dependent signaling pathway
Yu, H., Lin, T., & Tang, C. (2012) · The Prostate · doi:10.1002/pros.22544 · Cited by 45
Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor
Fox, A., Kaur, S., Li, B., Panesar, M., Saha, U., Davis, C., Dragoni, I., Colley, S., Ritchie, T. J., Bevan, S., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706139 · Cited by 45
Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan, D. C. F., Gera, L., Stewart, J. M., Helfrich, B. A., Zhao, T. L., Feng, W. Y., Chan, K. K., Covey, J. M., & Bunn, P. A. (2002) · PubMed · Cited by 45
Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems
Charignon, D., Späth, P., Martin, L., & Drouet, C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.723692 · Cited by 44
Roles of kinin B 1 and B 2 receptors in skin cancer pain produced by orthotopic melanoma inoculation in mice
Fujita, M., Andoh, T., Ohashi, K., Akira, A., Saiki, I., & Kuraishi, Y. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2009.10.010 · Cited by 43
Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways
Yang, W., Chang, J., Hsu, S., Li, T., Cho, D., Huang, C., Fong, Y., & Tang, C. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22383 · Cited by 43
Tissue Kallikrein Effectively Activates Latent Matrix Degrading Metalloenzymes
Tschesche, H., Michaelis, J., Kohnert, U., Fedrowitz, J., & Oberhoff, R. (1989) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-9543-4_84 · Cited by 42
In various tumour cell lines the peptide bradykinin B2 receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist
Drube, S., & Liebmann, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703764 · Cited by 42
Bradykinin Modulation of Tumor Vasculature: II. Activation of Nitric Oxide and Phospholipase A2/Prostaglandin Signaling Pathways Synergistically Modifies Vascular Physiology and Morphology to Enhance Delivery of Chemotherapeutic Agents to Tumors
Emerich, D. F., Dean, R. L., Snodgrass, P., Lafreniere, D., Agostino, M., Wiens, T., Xiong, H., Hasler, B. P., Marsh, J. P., Pink, M. M., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38780-4 · Cited by 42
Expression Patterns of Kinin-Dependent Genes in Endometrial Cancer
Orchel, J., Witek, Ł., Kimsa-Furdzik, M., Strzałka‐Mrozik, B., Kimsa‐Dudek, M., Olejek, A., & Mazurek, U. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e318259d8da · Cited by 42
Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers
Clements, J. A., & Mukhtar, A. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(97)00024-6 · Cited by 41
Traumatic Brain Contusions: A Clinical Role for the Kinin Antagonist CP-0127
Narotam, P. K., Rodell, T. C., Nadvi, S. S., Bhoola, K. D., Troha, J. M., Parbhoosingh, R., & van Dellen, J. R. (1998) · Acta Neurochirurgica · doi:10.1007/s007010050181 · Cited by 41
Discovery and therapeutic potential of kinin receptor antagonists
Whalley, E. T., Figueroa, C. D., Gera, L., & Bhoola, K. D. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.729038 · Cited by 41
Deletion of bradykinin B1 receptor reduces renal fibrosis
Wang, P. H. M., Cenedeze, M. A., Campanholle, G., Malheiros, D. M. A. C., Torres, H. A. M., Pesquero, J. B., Pacheco‐Silva, Á., & Câmara, N. O. S. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.018 · Cited by 40
Pro-inflammatory effects induced by bradykinin in a murine model of pleurisy
Fröde, T. S., Calixto, J. Β., & Medeiros, Y. S. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01005-4 · Cited by 39
Basal expression of bradykinin B1 receptor in the spinal cord in humans and rats
Ma, Q., & HEAVENS, R. P. (2001) · Neuroreport · doi:10.1097/00001756-200108080-00006 · Cited by 39
Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients
Kontos, C. K., Chantzis, D., Papadopoulos, I. N., & Scorilas, A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.036 · Cited by 39
Kinin receptors as targets for cancer therapy
Figueroa, C. D., Ehrenfeld, P., & Bhoola, K. D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.662957 · Cited by 38
Kallikrein activates bradykinin B2 receptors in absence of kininogen
Biyashev, D., Tan, F., Chen, Z., Zhang, K., Deddish, P. A., Erdös, E. G., & Hecquet, C. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00934.2005 · Cited by 38
Regulation of 92‐kDa Gelatinase B Activity in the Extracellular Matrix by Tissue Kallikrein
Ménashi, S., Fridman, R., Desrivières, S., Lu, H., Legrand, Y., & Soria, C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24787.x · Cited by 38
Brabykinin B1 Receptor Antagonism Is Beneficial in Renal Ischemia-Reperfusion Injury
Wang, P. H. M., Campanholle, G., Cenedeze, M. A., Feitoza, C. Q., Gonçalves, G. M., Landgraf, R. G., Jancar, S., Pesquero, J. B., Pacheco‐Silva, Á., & Câmara, N. O. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003050 · Cited by 38
Kinin B1 receptor antagonists with multi-enzymatic resistance properties
Neugebauer, W. A., Blais, P.-A., Hallé, S., Filteau, C., Regoli, D. C., & Gobeil, F. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-053 · Cited by 37
TGF-β potentiates airway smooth muscle responsiveness to bradykinin
Kim, J. H., Jain, D. K., Tliba, O., Yang, B., Jester, W. F., Panettieri, R. A., Amrani, Y., & Puré, E. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00027.2005 · Cited by 37
Expression of HER2 and bradykinin B1receptors in precursor lesions of gallbladder carcinoma
Toledo, C. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i11.1208 · Cited by 37
Identification of a B2 bradykinin receptor expressed by PC12 pheochromocytoma cells.
Nardone, J., Gerald, C., Rimawi, L., Song, L., & Hogan, P. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4412 · Cited by 35
Kinin B2 Receptor Mediates Induction of Cyclooxygenase-2 and Is Overexpressed in Head and Neck Squamous Cell Carcinomas
Zhang, W., Bhola, N. E., Kalyankrishna, S., Gooding, W. E., Hunt, J. L., Seethala, R. R., Grandis, J. R., & Siegfried, J. M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2197 · Cited by 35
Dual kinin B1 and B2 receptor activation provides enhanced blood–brain barrier permeability and anticancer drug delivery into brain tumors
Côté, J., Savard, M., Neugebauer, W. A., Fortin, D., Lepage, M., & Gobeil, F. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25327 · Cited by 34
Cross-talk between Carboxypeptidase M and the Kinin B1 Receptor Mediates a New Mode of G Protein-coupled Receptor Signaling
Zhang, X., Tan, F., Brovkovych, V. M., Zhang, Y., & Skidgel, R. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214940 · Cited by 33
Effect of a kinin B2 receptor antagonist on LPS‐ and cytokine‐induced neutrophil migration in rats
Santos, D. R., Calixto, J. Β., & de Souza, G. E. P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705236 · Cited by 33
Carboxypeptidase M Is a Positive Allosteric Modulator of the Kinin B1 Receptor
Zhang, X., Tan, F., & Skidgel, R. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.520791 · Cited by 32
Inhibiting Tissue Angiotensin-Converting Enzyme
Zisman, L. S. (1998) · Circulation · doi:10.1161/01.cir.98.25.2788 · Cited by 32
The renin angiotensin system regulates Kupffer cells in colorectal liver metastases
Wen, S. W., Ager, E. I., Neo, J. H., & Christophi, C. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25092 · Cited by 31
Antagonist, partial agonist and antiproliferative actions of B‐9870 (CU201) as a function of the expression and density of the bradykinin B1and B2receptors
Morissette, G., Houle, S., Gera, L., Stewart, J. M., & Marceau, F. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706982 · Cited by 30
Involvement of Intercellular Adhesion Molecule-1 Up-Regulation in Bradykinin Promotes Cell Motility in Human Prostate Cancers
Yu, H., Lin, T., & Tang, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140713329 · Cited by 30
Pharmacological, Pharmacokinetic, and Primate Analgesic Efficacy Profile of the Novel Bradykinin B1 Receptor Antagonist ELN441958
Hawkinson, J. E., Szoke, B. G., Garofalo, A. W., Hom, D. S., Zhang, H., Dreyer, M. L., Fukuda, J. Y., Chen, L., Samant, B., Simmonds, S., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120352 · Cited by 30
NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors: effect on inositol lipid turnover.
Ruggiero, M., Srivastava, S. K., Tp, F., Ron, D., & Eva, A. (1989) · PubMed · Cited by 30
Evidence for involvement of ROCK signaling in bradykinin-induced increase in murine blood–tumor barrier permeability
Ma, T., Liu, L., Wang, P., & Xue, Y. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0685-3 · Cited by 27
Comparison of tissue kallikrein and kinin receptor expression in gastric ulcers and neoplasms
Sawant, S. S., Snyman, C., & Bhoola, K. D. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00118-7 · Cited by 26
Role of vascular Kinin B1 and B2 receptors in endothelial nitric oxide metabolism
Loiola, R. A., Reis, F. C. G., Kawamoto, E. M., Scavone, C., Abdalla, D. S. P., Fernandes, L., & Pesquero, J. B. (2011) · Peptides · doi:10.1016/j.peptides.2011.06.010 · Cited by 26
Protein western array analysis in human pituitary tumours: insights and limitations
Ribeiro‐Oliveira, A., Franchi, G. M., Kola, B., Dalino, P., Pinheiro, S. V. B., Salahuddin, N., Musat, M., Góth, M., Czirják, S., Hanzély, Z., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0003 · Cited by 26
Downregulation of bradykinin B2receptor in human fibroblasts during prolonged agonist exposure
Blaukat, A., Micke, P., Kalatskaya, I., Faußner, A., & Müller‐Esterl, W. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00034.2003 · Cited by 25
Expression of Metallopeptidases and Kinin Receptors in Swine Oropharyngeal Tissues: Effects of Angiotensin I-Converting Enzyme Inhibition and Inflammation
Moreau, M. E., Dubreuil, P., Molinaro, G., Chagnon, M., Müller‐Esterl, W., Lepage, Y., Marceau, F., & Adam, A. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088005 · Cited by 25
Expression and localisation of kinin receptors in colorectal polyps
Żelawski, W., Machnik, G., Nowaczyk, G., Plewka, D., Lorenc, Z., Sosada, K. A., & Stadnicki, A. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.016 · Cited by 25
Carboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output
Zhang, X., Tan, F., Brovkovych, V. M., Zhang, Y., Lowry, J., & Skidgel, R. A. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0290 · Cited by 24
Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma
Chee, J., Singh, J., Naran, A., Misso, N. L. A., Thompson, P. J., & Bhoola, K. D. (2007) · Biological Chemistry · doi:10.1515/bc.2007.139 · Cited by 23
Contribution of Endogenous Bradykinin to Fibrinolysis, Inflammation, and Blood Product Transfusion Following Cardiac Surgery: A Randomized Clinical Trial
Balaguer, J. M., Yu, C., Byrne, J. G., Ball, S. K., Petracek, M. R., Brown, N. J., & Pretorius, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.249 · Cited by 23
MARCKS dephosphorylation is involved in bradykinin‐induced neurite outgrowth in neuroblastoma SH‐SY5Y cells
Tanabe, A., Shiraishi, M., Negishi, M., Saito, N., Tanabe, M., & Sasaki, Y. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22763 · Cited by 23
Bradykinin augments the in vitro migration of nonsensitized lymphocytes.
Rg, M., & Vickers, K. (1989) · PubMed · Cited by 22
The kallikrein–kinin-system in head and neck squamous cell carcinoma (HNSCC) and its role in tumour survival, invasion, migration and response to radiotherapy
Beck, C., Piontek, G., Haug, A., Baş, M., Knopf, A., Stark, T., Mißlbeck, M., Rudelius, M., Reiter, R., Brandstetter, M., et al. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.001 · Cited by 21
Activation of the Kinin B1 Receptor Attenuates Melanoma Tumor Growth and Metastasis
Dillenburg-Pilla, P., Maria, A. G., Reis, R. I., Floriano, E. M., Pereira, C. D., Lucca, F. L. D., Ramos, S. G., Pesquero, J. B., Jasiulionis, M. G., & Costa-Neto, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064453 · Cited by 21
Effect of Bradykinin Receptor Antagonists on Vincristine- and Streptozotocin-Induced Hyperalgesia in a Rat Model of Chemotherapy-Induced and Diabetic Neuropathy
Bujalska‐Zadrożny, M., Tatarkiewicz, J., & Gumułka, S. W. (2007) · Pharmacology · doi:10.1159/000110788 · Cited by 21
Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7
Elliott, P. J., Hayward, N. J., Dean, R. L., & Bartus, R. T. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00041-0 · Cited by 21
Effects of neuropeptides on human lung and breast cancer cells.
Bunn, P. A., Dienhart, D. G., Chan, D., Tagawa, M., & Jewett, P. B. (1992) · PubMed · Cited by 21
Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant
Gomis, A., Meini, S., Miralles, A., Valenti, C., Giuliani, S., Belmonte, C., & Maggi, C. A. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.03.013 · Cited by 20
Esophageal cancer in African blacks of Kwazulu Natal, South Africa: an epidemiological brief.
Dlamini, Z., & Bhoola, K. D. (2005) · PubMed · Cited by 20
Metabolism-Resistant Bradykinin Antagonists: Development and Applications
Stewart, J. M., Gera, L., York, E. J., Chan, D. C. F., Whalleya, E. J., Bunn, P. A., & Vavrek, R. J. (2001) · Biological Chemistry · doi:10.1515/bc.2001.006 · Cited by 20
Functional and molecular characterization of kinin B1 and B2 receptors in human bladder cancer: implication of the PI3Kγ pathway
Sgnaolin, V., Pereira, T. C. B., Bogo, M. R., Zanin, R. F., Battastini, A. M. O., Morrone, F. B., & Campos, M. M. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9907-6 · Cited by 19
Bradykinin receptor antagonists: therapeutic implications.
Sharma, J. N., & Al-Dhalmawi, G. S. (2003) · PubMed · Cited by 19
Kinin-Stimulated B1 Receptor Signaling Depends on Receptor Endocytosis Whereas B2 Receptor Signaling Does Not
Enquist, J., Sandén, C., Skröder, C., Mathis, S. A., & Leeb-Lundberg, L. M. F. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1126-9 · Cited by 18
Bradykinin binding sites in healthy and carcinomatous human lung
Trifilieff, A., Lach, E., Dumont, P., & Gies, J. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14876.x · Cited by 18
Opioids increase bladder cancer cell migration via bradykinin B2 receptors
Kampa, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1063 · Cited by 17
Visualisation of transforming growth factor-β1, tissue kallikrein, and kinin and transforming growth factor-β receptors on human clear-cell renal carcinoma cells
Moodley, R., Snyman, C., Odhav, B., & Bhoola, K. D. (2005) · Biological Chemistry · doi:10.1515/bc.2005.045 · Cited by 17
EFFECTS OF BRADYKININ ON CYTOPLASMIC CALCIUM AND MOTILITY IN MURINE BLADDER TUMOR CELLS
BABA, K., & Yamaguchi, O. (2001) · The Journal of Urology · doi:10.1097/00005392-200101000-00075 · Cited by 16
Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors
Rodrigues, E. S., Filippelli-Silva, R., Martin, R. P., de Oliveira, S. M., Nakaie, C. R., Sabatini, R. A., Merino, V. F., Pesquero, J. B., Bäder, M., & Shimuta, S. I. (2013) · Peptides · doi:10.1016/j.peptides.2013.01.002 · Cited by 15
The bradykinin B1 receptor antagonist R-954 inhibits Ehrlich tumor growth in rodents
Fernandes, P. D., Gomes, N. D. M., & Sirois, P. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.023 · Cited by 15
Self-citation
Cardiovascular expression of inflammatory signaling molecules, the kinin B1 receptor and COX2, in the rabbit: Effects of LPS, anti-inflammatory and anti-hypertensive drugs
Bawolak, M., Touzin, K., Moreau, M. E., Désormeaux, A., Adam, A. A., & Marceau, F. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.09.004 · Cited by 13
Role of human tissue kallikrein in gastrointestinal stromal tumour invasion
Dominek, P., Campagnolo, P., H-Zadeh, M., Kränkel, N., Chilosi, M., Sharman, J. A., Caporali, A., Mangialardi, G., Spinetti, G., Emanueli, C., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605906 · Cited by 12
Bradykinin B1 receptor antagonists: a patent update 2009 – 2012
Bozó, É., Éles, J., & Keserű, G. M. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.730521 · Cited by 12
Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexate
Papachristopoulou, G., Talieri, M., & Scorilas, A. (2012) · Tumor Biology · doi:10.1007/s13277-012-0558-1 · Cited by 11
The bradykinin B2 receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines
Garnovskaya, M. N., Kramarenko, I. I., Morinelli, T. A., Bunni, M. A., & Raymond, J. R. (2012) · Cancer Management and Research · doi:10.2147/cmar.s31847 · Cited by 11
Kinin-generating cellular model obtained from human glioblastoma cell line U-373.
Guevara-Lora, I., Blonska, B., Faußner, A., & Kozik, A. (2013) · Acta Biochimica Polonica · doi:10.18388/abp.2013_1985 · Cited by 11
Tissue kallikrein and kinin receptor expression in an angiogenic co-culture neuroblastoma model
Naidoo, S., & Raidoo, D. M. (2006) · Metabolic Brain Disease · doi:10.1007/s11011-006-9008-3 · Cited by 10
Bradykinin and Met-T-kinin-Leu stimulated PGE2 production by rat macrophage and fibroblast.
Sakamoto, W., Kaga, M., Handa, H., Gotoh, K., Suzuki, S., Fujie, K., Inoue, N., & Nishihira, J. (1994) · PubMed · Cited by 10
Effects of kallikrein-related peptidase 14 gene inhibition by small interfering RNA in ovarian carcinoma cells
Huirong, S. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.625 · Cited by 9
Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression
Rastelli, V. M. F., Oliveira, M. A., Eichler, R. A. D. S., Tostes, R. C., Nigro, D., de Carvalho, M. H. C., & Fortes, Z. B. (2008) · Peptides · doi:10.1016/j.peptides.2007.11.022 · Cited by 8
Pharmacological studies on lymphocytes. 1. Effects of 5-hydroxytryptamine, bradykinin, and lymphokines on the migration of lymphocytes in vitro.
Paegelow, I., & Lange, P. (1982) · PubMed · Cited by 7
Cellular localization of bradykinin B1 receptor mRNA in the human kidney
Wang, D.-Z., Chao, L., & Chao, J. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00011-2 · Cited by 6
Epithelial ovarian cancer: A feasible plan for adjunctive treatment using simultaneous acyclovir, ambrisentan, captopril, disulfiram, fluvoxamine-augmented ramelteon, icatibant, imiquimod peritoneal lavage, and plerixafor
Kast, R. E. (2012) · journal of cancer therapeutics and research · doi:10.7243/2049-7962-1-2 · Cited by 4
[Correlation between the expression of mRNA of histones H2B and H4 and mRNA of kinin receptors B1 and B2 assessed by QRT-PCR in vulvar cancer].
Olejek, A., Mazurek, U. M., Kuśmierz, D., Michalska, A., & Wilczok, T. (2002) · PubMed · Cited by 2
ACE inhibitors as activators of kinin receptors
Kugaevskaya, E. V., & Eliseeva, Y. E. (2010) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750810040013 · Cited by 1
Ace inhibitors - activators of kinin receptors
Kugaevskaya, E. V., & Eliseeva, Y. E. (2011) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20115703282 · Cited by 1

Research works printed but not linked: 1

Chee, 2008, Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer, Biol. Chem., 389, 1225, 10.1515/BC.2008.139 · DOI

Sorted by citations

Strategies to improve the EPR effect: A mechanistic perspective and clinical translation
Ikeda-Imafuku, M., Wang, L. L.-W., Rodrigues, D., Shaha, S., Zhao, Z., & Mitragotri, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.043 · Cited by 330
Biochemical aspects of the inflammatory process: A narrative review
Soares, C. L. R., Wilairatana, P., Silva, L. R., Moreira, P. S., Barbosa, N. M. M. V., da Silva, P. R., Coutinho, H. D. M., de Menezes, I. R. A., & Felipe, C. F. B. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115764 · Cited by 187
Should safety of the flu vaccine for cancer patients be reexamined?
Paessler, S., & Veljković, V. (2018) · F1000Research · doi:10.12688/f1000research.13428.1 · Cited by 116
Targeting endothelial permeability in the EPR effect
Lahooti, B., Akwii, R. G., Zahra, F. T., Sajib, M. S., Λάμπρου, Μ., Alobaida, A., Lionakis, M. S., Mattheolabakis, G., & Mikelis, C. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.039 · Cited by 114
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030389 · Cited by 98

See all 134

Authors: da Costa, P. L. N., Sirois, P., Tannock, I. F., & Chammas, R.
Affiliations: University of Toronto (CA)
Universidade de São Paulo (BR)
ORCID: Tannock, Ian F.
Chammas, Roger
Venue: Cancer Letters
Publisher: Elsevier BV
Published: 2014-04
Volume: 345
Issue: 1
Pages: 27-38
ISSN: 0304-3835 (ISSN-L)
DOI: 10.1016/j.canlet.2013.12.009
OpenAlex: W2090131666
Cited by: 133
References: 205
Citations by year: 2026: 3 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 16 · 2021: 17 · 2020: 8 · 2019: 6 · 2018: 17 · 2017: 6 · 2016: 21 · 2015: 6 · 2014: 4
FWCI: 1.41
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
Locations: Cancer Letters (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: Fundação de Amparo à Pesquisa do Estado de São Paulo
Topics: Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pineapple and bromelain studies
Keywords: kinin receptors, B1 receptor, bradykinin B2 receptor, kinin receptor antagonists, cancer therapy, tumor microenvironment, angiogenesis, metastasis, renin-angiotensin system, autocrine signaling, macrophage activation, dendritic cells
MeSH terms: Animals, Humans, Neoplasms, Signal Transduction, Receptor, Bradykinin B2, Receptor, Bradykinin B1, Molecular Targeted Therapy, Bradykinin B2 Receptor Antagonists, Bradykinin B1 Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of kinin receptors in cancer and therapeutic opportunities

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks